| scholarly article | Q13442814 |
| P50 | author | Donald M. Anderson | Q88717534 |
| P2093 | author name string | Thomas Roth | |
| Christopher Lines | |||
| Duane Snavely | |||
| Kristel Vandormael | |||
| Paulette Ceesay | |||
| P2860 | cites work | Estradiol and testosterone modulate the anesthetic action of the GABA-A agonist THIP, but not of the neurosteroid 3alpha,5beta-pregnanolone in the rat. | Q44699583 |
| Sex differences and the effect of gaboxadol and zolpidem on EEG power spectra in NREM and REM sleep. | Q45987247 | ||
| A 2-week efficacy and safety study of gaboxadol and zolpidem using electronic diaries in primary insomnia outpatients | Q46061312 | ||
| Gender and age differences in polysomnography findings and sleep complaints of patients referred to a sleep laboratory | Q48412641 | ||
| The effect of gender on autonomic and respiratory responses during sleep among both young and middle-aged subjects | Q48457573 | ||
| Efficacy of the selective extrasynaptic GABA A agonist, gaboxadol, in a model of transient insomnia: a randomized, controlled clinical trial | Q48458311 | ||
| Short-term treatment with gaboxadol improves sleep maintenance and enhances slow wave sleep in adult patients with primary insomnia | Q48461687 | ||
| The selective extrasynaptic GABAA agonist, gaboxadol, improves traditional hypnotic efficacy measures and enhances slow wave activity in a model of transient insomnia | Q48466641 | ||
| Effect of short-term treatment with gaboxadol on sleep maintenance and initiation in patients with primary insomnia | Q48472265 | ||
| Sex differences in insomnia: a meta-analysis | Q48514727 | ||
| Sleep of aging women and men: back to basics | Q48514870 | ||
| Sex differences in delta and alpha EEG activities in healthy older adults | Q48517555 | ||
| Chronotype and sex effects on sleep architecture and quantitative sleep EEG in healthy young adults | Q48537874 | ||
| The effects of age and gender on sleep EEG power spectral density in the middle years of life (ages 20-60 years old). | Q48694594 | ||
| Gender differences in irritable bowel syndrome | Q78439568 | ||
| Evolving knowledge of sex differences in brain structure, function, and chemistry | Q22337351 | ||
| Tolerability, pharmacokinetics and night-time effects on postural sway and critical flicker fusion of gaboxadol and zolpidem in elderly subjects | Q33156940 | ||
| The biology of human sex differences | Q33239072 | ||
| Gender differences in drug responses | Q33264752 | ||
| Central nervous system side effects associated with zolpidem treatment | Q33842608 | ||
| Insomnia: definition, prevalence, etiology, and consequences | Q34006700 | ||
| Sex differences in the sleep EEG of young adults: visual scoring and spectral analysis. | Q34475473 | ||
| Treating insomnia: Current and investigational pharmacological approaches | Q34552286 | ||
| Getting excited about GABA and sex differences in the brain | Q34710241 | ||
| Gender differences in drug effects: implications for anesthesiologists | Q35089206 | ||
| Sex differences in pharmacokinetics and pharmacodynamics | Q35639177 | ||
| Gaboxadol--a new awakening in sleep | Q36348054 | ||
| Effect of gaboxadol on sleep in adult and elderly patients with primary insomnia: results from two randomized, placebo-controlled, 30-night polysomnography studies | Q36948422 | ||
| Gender and age differences in expression of GABAA receptor subunits in rat somatosensory thalamus and cortex in an absence epilepsy model | Q37255508 | ||
| The measurement of disability. | Q41219166 | ||
| Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia | Q44679941 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | primary insomnia | Q2110202 |
| P304 | page(s) | 30-39 | |
| P577 | publication date | 2010-02-01 | |
| P1433 | published in | The Journal of Clinical Sleep Medicine | Q15766748 |
| P1476 | title | Effect of gaboxadol on patient-reported measures of sleep and waking function in patients with Primary Insomnia: results from two randomized, controlled, 3-month studies | |
| P478 | volume | 6 |
| Q36675803 | A study of subunit selectivity, mechanism and site of action of the delta selective compound 2 (DS2) at human recombinant and rodent native GABA(A) receptors |
| Q31171354 | Clinical profile of suvorexant for the treatment of insomnia over 3 months in women and men: subgroup analysis of pooled phase-3 data |
| Q37319964 | Comparing the discriminative stimulus effects of modulators of GABAA receptors containing α4-δ subunits with those of gaboxadol in rats |
| Q35311652 | EEG power spectra response to a 4-h phase advance and gaboxadol treatment in 822 men and women |
| Q37349496 | Effects of early-life exposure to THIP on phenotype development in a mouse model of Rett syndrome |
| Q34238302 | Electroencephalographic power spectral density profile of the orexin receptor antagonist suvorexant in patients with primary insomnia and healthy subjects |
| Q36608004 | Extrasynaptic GABAA receptors in rat pontine reticular formation increase wakefulness |
| Q28264334 | GABA site agonist gaboxadol induces addiction-predicting persistent changes in ventral tegmental area dopamine neurons but is not rewarding in mice or baboons |
| Q28272266 | The orexin antagonist SB-649868 promotes and maintains sleep in men with primary insomnia |
Search more.